Clinical Trial Update: IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer

View source ↗

Summary

An update on the IMI PROTECT Work Package 2 trial investigating calcium channel blockers and cancer in hypertension. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Calcium channel blockers (calcium channel blocker)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Status: COMPLETED